Fertility Drugs And Birth Defects - The Hidden Risk Of Induced Ovulation

In what can only be described as the drug industries'Yet, in spite of this knowledge, the FDA took no
version of the shell game, over the past threesteps to insure that the users of fertility drugs and
decades the manufacturers of fertility drugs havetheir doctors were aware of these studies. To the
demonstrated with exquisite skill that what you don'tcontrary, between 1967 and 1995, the Clomid
see may as well not exist.package insert assured prescribing physicians that "no
In 1972 it was reported in a scientific journal that in acausative evidence of a deleterious effect of Clomid
combined study involving Clomid (clomiphene citrate)therapy on the human fetus (had) been seen."
and Pergonal (human menopausal gonadotropin/hMG),During the mid-1990s it was determined that NTDs
there was twice the expected frequency of Downand other specific congenital anomalies can occur
syndrome in the offspring of women using thosewhen the early embryo is denied an adequate supply
drugs. The subject birth defect, which is usuallyof cholesterol. In addition to being an important
caused by an abnormal chromosome (trisomy 21) inconstituent of the human cell, it has been discovered
older women, could not be attributed to the averagethat a gene (Sonic hedgehog/Shh), which dictates
age of the study populations. The following year,how certain organs are to form during early
another published study concluded that there was anpregnancy, must bind with cholesterol to properly
increased incidence of abnormal chromosomes in firstfunction. Absent a sufficient level of cholesterol, Shh
trimester spontaneous abortions (miscarriages) incannot effectively communicate and malformations
women conceiving with fertility drugs, includingoccur.
clomiphene and hMG, when compared to the generalThe discovery about the importance of cholesterol in
population and women who naturally conceived twothe development of embryonic organs was a major
or more cycles after using drugs to induce ovulation.breakthrough toward understanding how fertility
In yet another published paper during the same yeardrugs can malform a human embryo. Although not
(1973), scientists described a study establishing thatwidely known, clomiphene citrate is a cholesterol
clomiphene was capable of causing abnormalinhibiting drug -- it inhibits the function of an enzyme
chromosomes in the endometrium (lining of thein the body that normally converts desmosterol to
uterus) of women using the drug.cholesterol. The suppression of cholesterol during the
Yet, even though this evidence was presented tocritical first few weeks of pregnancy can also occur
the FDA over 3 decades earlier, the current labelingas a consequence of another function of fertility
(package inserts) for these drugs make absolutely nodrugs; namely, their demonstrated ability to
reference to these studies.significantly elevate normal levels of estrogen. It has
But it doesn't stop there. In 1983, a scientific articlebeen established that there is an inverse correlation
appearing in the International Journal of Epidemiology,between the level of estrogen and the level of
reported on a study in which they found a significantcholesterol: the higher the estrogen, the lower the
increase in the incidence of limb reduction defectscholesterol.
(absence of limbs) following the use of fertility drugs,A recent published study (January 2008)
including clomiphene citrate. And beginning in late 1987,demonstrated this very subject. The researchers
a series of published scientific studies beganfound that when women, who did not develop
appearing in medical journals in which the researchersovarian follicular cysts, were exposed to clomiphene
reported on an increased incidence of neural tubeduring the first 2 months of pregnancy, they had a
defects (NTDs) following use of fertility drugs,350 percent increased risk of having a baby with a
including their use during in vitro fertilization (IVF). Anneural tube defect. However, if the fertility drug also
NTD results when the neural tube fails to fully closecaused the development of ovarian cysts -- which
during the 4th week of pregnancy, leaving an opencontain high levels of estrogen -- the incidence of
cranium (anencephaly) and/or spinal column (spinaNTDs shot even higher to a 540 percent increased
bifida). One scientist, after combining the results of 3risk. The authors concluded that when accompanied
of these studies in a meta-analysis, stated that "theby follicular cysts, the "treatment with clomiphene
three studies, when combined, do indicate that themay have a role in the genesis of NTD." Although
association between ovulation induction and NTD isadministered prior to conception, clomiphene can be
real." He calculated that the odds of the combinedbiologically active up to 54 days after ingestion, and is
statistics (a 194 percent increased risk) occurring bythus present during early pregnancy in every woman
chance was only 4 in a thousand (P = 0.004). In stillwho conceives during a treatment cycle.
another NTD study published in 1991, the authorsThe real tragedy about withholding this information
commented that "these data (a 136 percentfrom users of fertility drugs and their doctors is that
increased risk), combined with those previouslythere currently exists a simple means to substantially
published, indicate an association between stimulationreduce or eliminate the risk of birth defects while
of ovulation and increased rate of NTD."continuing to take these drugs.